Skip to content
Search

Latest Stories

Covid-19 impacts human brain's cerebellum more than other regions: Study

According to the study, the research reinforces the understanding that Covid-19 can cause alterations in the brain

Covid-19 impacts human brain's cerebellum more than other regions: Study

A recent study conducted by the Rotman Research Institute and Sunnybrook Hospital in Toronto, Canada, has revealed that the cerebellum, a region of the human brain also known as the hindbrain, may be more susceptible to Covid-19 infections compared to other brain regions.

The study utilised an innovative MRI technique known as correlated diffusion imaging (CDI) to examine these findings.


According to the study, the research reinforces the understanding that Covid-19 can cause alterations in the brain.

CDI, developed by Alexander Wong, a professor of systems design engineering at the University of Waterloo in Canada, is a novel form of MRI that provides enhanced visualisation of the movement of water molecules in brain tissue.

By capturing and combining MRI signals at various gradient pulse strengths and timings, CDI can effectively highlight differences in water molecule motion.

The study's findings, published in the journal Human Brain Mapping, shed light on the potential vulnerability of the cerebellum to Covid-19 infections and contribute to a deeper understanding of the virus's impact on the brain.

CDI, an imaging technique developed by Wong, had originally been designed as an improved measure for detecting cancer.

However, in a recent study, CDI was utilised to examine the impact of Covid-19 on the human brain.

The CDI imaging specifically focused on the frontal-lobe white matter, located in the cerebrum of the brain, and revealed that Covid-19 patients exhibited a less restricted diffusion of water molecules in this region.

Conversely, in the cerebellum of patients with Covid-19, the CDI imaging showed a more restricted diffusion of water molecules.

"Some may think Covid-19 affects just the lungs," Wong said. "What was found is that this new MRI technique that we created is very good at identifying changes to the brain due to Covid-19. Covid-19 changes the white matter in the brain."

In addition to being one of the few studies showing Covid-19's effects on the brain, the study said that it is the first to report diffusion abnormalities in the white matter of the cerebellum.

While the study was originally designed to show changes to the brain from Covid, rather than specific damage, it said that many of the potential sources of such changes link to disease and damage.

Wong suggested future tests could focus on whether Covid-19 actually damages brain tissue.

Additional studies could also determine, he said, if Covid-19 can change the brain's grey matter.

"Hopefully, this research can lead to better diagnoses and treatments for Covid-19 patients," Wong said.

(PTI)

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
London temple project for Shree Banke Bihari launched

London temple project for Shree Banke Bihari launched

Mahesh Liloriya

The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.

The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”

Keep ReadingShow less
Dickie and Watt

Dickie and Watt launched BrewDog at the age of 24

Getty Images

BrewDog co-founder Martin Dickie leaves after 17 years as James Watt steps back

Highlights:

  • Martin Dickie has announced his departure from BrewDog and the alcohol industry.
  • He co-founded the Ellon-based brewer with James Watt in 2007.
  • Dickie cited family time and personal reasons for his exit.
  • His departure follows recent bar closures as part of a company restructuring.
  • BrewDog confirmed no further leadership changes will follow.

BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.

Early beginnings

Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.

Keep ReadingShow less